VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014

Jun 26, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-06-24

Reporting Person: Sachdev Amit (SVP, Global Gov. Strategy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-24	Common Stock	M	15250	$33.55	Acquired	53921	Direct
2014-06-24	Common Stock	M	7000	$33.28	Acquired	60921	Direct
2014-06-24	Common Stock	M	20000	$33.82	Acquired	80921	Direct
2014-06-24	Common Stock	S	42250	$98.03	Disposed	38671	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-24	Stock Option (right to buy)	$33.55	M	15250	Disposed	2019-02-04	Common Stock (15250)	Direct
2014-06-24	Stock Option (right to buy)	$33.28	M	7000	Disposed	2019-07-15	Common Stock (7000)	Direct
2014-06-24	Stock Option (right to buy)	$33.82	M	20000	Disposed	2020-07-13	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	882	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.

F2: Fully vested.

F3: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 7/14/2010.